Table 1.
Patient baseline characteristics
| Total (N = 29) | |
|---|---|
| Age | |
| Median (range) | 50.0 (28.0–76.0) |
| Gender | |
| Female | 15 (51.7%) |
| Male | 14 (48.3%) |
| ECOG Performance Score | |
| 0 | 12 (41.4%) |
| 1 | 15 (51.7%) |
| 2 | 2 (6.9%) |
| Race | |
| White | 27 (93.1%) |
| Black or African American | 1 (3.4%) |
| Ethnicity | |
| Not Hispanic or Latino | 28 (96.6%) |
| Months from Diagnosis to On Study | |
| Median (range) | 27.6 (1.3–216.8) |
| Tumor Status | |
| Resected with no residual | 9 (31.0%) |
| Resected with known residual | 5 (17.2%) |
| Unresected | 6 (20.7%) |
| Recurrent | 9 (31.0%) |
| Number of Prior Chemotherapy Regimens | |
| 0 | 3 (10.3%) |
| 1 | 10 (34.5%) |
| 2 | 7 (24.1%) |
| 3 | 5 (17.2%) |
| 4 | 3 (10.3%) |
| 5 | 1 (3.4%) |
| Prior Other Cancer | |
| Yes | 2 (6.9%) |
| No | 27 (93.1%) |
| Prior Surgery | |
| Yes | 27 (93.1%) |
| No | 2 (6.9%) |
| Number of Metastasis | |
| 1 | 4 (13.8%) |
| 2 | 11 (37.9%) |
| 3 | 10 (34.5%) |
| ≥4 | 4 (13.8%) |
| Abdominal Metastasis (excluding liver, soft tissue) | |
| Present | 15 (51.7%) |
| Bone Metastasis | |
| Present | 5 (17.2%) |
| Liver Metastasis | |
| Present | 22 (75.9%) |
| Lung Metastasis | |
| Present | 20 (69.0%) |
| Nodal Metastasis | |
| Present | 9 (31.0%) |
| Subcutaneous Metastasis | |
| Present | 1 (3.4%) |
| Other Metastasis | |
| Present | 3 (10.3%) |